NewsRoom Articles - Page 56 of 1389

WednesdayMay 28, 2025 9:45 am

NRx Pharmaceuticals Inc. (NASDAQ: NRXP) Announces $10.3 Million Financing to Expand HOPE Clinic Network, Advances FDA Drug Approval

Subsidiary HOPE Therapeutics signed a $7.8 million debt financing term sheet with Universal Capital. Combined with a prior strategic investment, for which a financing term sheet has also been signed, the total financing investment, assuming both are closed, represents an expected $10.3 million for HOPE acquisition funding, supporting initial acquisitions of Dura Medical, Kadima, and NeuroSpa clinics. The expanding HOPE clinic network will deliver neuroplastic therapies for depression and PTSD, including ketamine and TMS. NRx continues regulatory progress for NRX-100 (IV ketamine) and NRX-101 (oral bipolar depression therapy). The FDA waived NRx’s $4.3 million drug application fee, and patents could…

WednesdayMay 28, 2025 9:00 am

Who Is Building Ecuador’s Next Modern Mine? A Global Mining Investment Destination

Ecuador is on the verge of a mine-building surge, as President Daniel Noboa's reelection coincides with high metals prices and a handful of projects ready for development. He will start his second term on May 24 on the brink of a mining bonanza, with six projects at the development stage representing at least US$10 billion in investment slated for construction decisions during the 2025-2029 presidential term. During his current term, truncated to about 18 months as he is completing the term of the previous incumbent, Guillermo Lasso, Noboa has been an advocate of growing Ecuador’s mining sector to boost employment,…

TuesdayMay 27, 2025 10:30 am

Newton Golf Company Inc. (NASDAQ: NWTG) Unveils Fast Motion Shaft for Next-Level Play, Game-Changing Innovation

Newton Golf’s new Fast Motion shaft exemplifies how a company can use innovation to sharpen its competitive edge. The Fast Motion shaft incorporates several proprietary technologies that Newton Golf has developed over time. This product launch is timely, as the golf equipment market continues to experience growth, driven by a surge in participation and a demand for premium gear. Innovation has long been a driving force behind business growth, market disruption and brand longevity across nearly every sector of the global economy. In the world of sports equipment, few areas are as ripe for innovation as golf, where players are…

TuesdayMay 27, 2025 9:45 am

SolarBank Corp. (NASDAQ: SUUN) (Cboe CA: SUNN) (FSE: GY2) Reports 395% Asset Growth in Current Fiscal Year, Focuses on Long-Term Recurring Revenue Strategy

Total assets rose to $194 million as of March 31, 2025, as compared to the end of the last fiscal year, following a key acquisition. Revenue from the company’s independent power producer segment grew from $0.3 million to $6.6 million. This reflects the company’s focus on long-term income-generating assets, versus short-term engineering, procurement, and construction/project sales. During the third quarter, SolarBank executed several operational milestones that align with this longer-term focus. Disseminated on behalf of SolarBank Corporation SolarBank (NASDAQ: SUUN) (Cboe CA: SUNN) (FSE: GY2), a premier developer and owner of renewable and clean energy projects, specializing in distributed and…

TuesdayMay 27, 2025 9:00 am

Cannabis Means Business – Conference & Expo to be Held as a B2B Conference in New York City

The Cannabis Means Business Conference & Expo will be held on June 4-5, 2025, in New York City as a two-day B2B event. Formerly known as CWBExpo, CMB has been operational since 2015. CMB highlights include: The pre-show workshops and rooftop party will be held on June 3, 2025. The Expo & Conference & O2VAPE Industry Yacht Party will be held on June 4 The Expo & Conference & Women in Cannabis Business Luncheon will be held on June 5 CMB caters to the innovative, business, and creative needs of the vibrant cannabis industry in New York City. It offers tremendous growth…

FridayMay 23, 2025 12:00 pm

Nicola Mining Inc. (TSX.V: NIM) (OTCQB: HUSIF) Featured in Noble Research Report, Earns ‘Outperform’ Rating and C$0.70 and US$0.50 Price Target

Noble Capital Markets Research released a comprehensive analysis of Nicola Mining. Nicola distinguishes itself among junior mining companies by combining exploration potential with operational cash flow, report states. Noble report also noted the company’s “superb corporate governance,” led by CEO Peter Espig, former 20-year Goldman Sachs banker. Nicola Mining (TSX.V: NIM) (OTCQB: HUSIF), a junior mining company based in British Columbia, has recently been the focus of a comprehensive analysis by Noble Capital Markets Research (https://nnw.fm/m8eHs). The report gave the company an "Outperform" rating and a 12-month price target of C$0.70 and US$0.50 per share while highlighting Nicola Mining's diversified asset…

FridayMay 23, 2025 11:15 am

Soligenix Inc. (NASDAQ: SNGX) Innovative Treatment to Combat Bacterial Infection Fills Urgent Need for Alternatives to Antibiotics

The overuse and misuse of antibiotics have led to the emergence of antibiotic-resistant bacteria, posing a significant threat to public health. Soligenix’s SGX943 is a novel broad-spectrum therapy designed to treat bacterial infections without relying on conventional antibiotics. Preclinical studies have demonstrated the efficacy of SGX943 in various models of bacterial infection. In the face of escalating antibiotic resistance, the medical community is urgently seeking alternative treatments for bacterial infections. Soligenix (NASDAQ: SNGX), a late-stage biopharmaceutical company, is at the forefront of this effort with its development of SGX943 (dusquetide), a novel broad-spectrum therapy designed to combat bacterial infections without relying…

FridayMay 23, 2025 10:30 am

NRx Pharmaceuticals Inc. (NASDAQ: NRXP) Subsidiary, HOPE Therapeutics, to Expand Interventional Psychiatry Treatment with Kadima Institute Acquisition

Kadima Neuropsychiatry Institute is expected to become the clinical model for HOPE Therapeutics’ nationwide network of psychiatric clinics. The acquisition brings profitability and is expected to be accretive to both revenue and EBITDA. Kadima’s founder and medical director, Dr. David Feifel, a leader in interventional psychiatry, will join HOPE as Chief Medical Innovation Officer. NRx’s pipeline includes investigational drugs for suicidal bipolar depression and chronic pain. HOPE is targeting 30 clinic acquisitions by the end of 2025, projecting $100M in annual revenue. NRx Pharmaceuticals (NASDAQ: NRXP), a clinical-stage biopharmaceutical company, and its wholly owned subsidiary HOPE Therapeutics, Inc., a medical…

FridayMay 23, 2025 9:45 am

FAVO Capital Inc. (FAVO): Positioned to Capitalize on Small Business Lending Revival

FAVO Capital has filed to uplist to Nasdaq, aiming to scale its private credit model U.S. small business lending is drawing renewed policy attention amid fintech innovation FAVO strengthening strategic partnership with Stewards Investment Capital Limited through Series A equity Investment Recently announced the voluntary conversion of all outstanding Super Voting Series C Preferred Shares into common stock As traditional banks retreat from Main Street, alternative lenders are stepping up to fill the gap, reshaping the $1.7 trillion small business lending market in the process. With policymakers calling for renewed focus on small business financing and digital platforms redefining borrower…

FridayMay 23, 2025 9:00 am

Intelligent Bio Solutions Inc. (NASDAQ: INBS) Progressing with FDA Clearance for Fingerprint Drug Testing as Global Demand Grows

Intelligent Bio Solutions remains on track for a 2025 U.S. launch of its non-invasive Intelligent Fingerprinting Drug Screening System. The company’s FDA 510(k) submission included validation studies showing 94.1% accuracy in detecting opiates through fingerprint sweat. INBS is already active in 24 countries, with over 450 commercial accounts globally, and adoption growing across diverse industries, including logistics, mining, retail, and marine operations. The firm is expanding its distributor network to support localized growth ahead of its U.S. market entry. Intelligent Bio Solutions (NASDAQ: INBS), a medical technology company specializing in rapid, non-invasive testing solutions, is preparing for its expected U.S.…

Financial news and publishing for public and private companies

Contact us: 512.354.7000